Mayne Pharma Group Limited
符号: MYX.AX
ASX
6.8
AUD今天的市场价格
-2.3865
市盈率
-0.0091
PEG比率
578.51M
MRK市值
- 0.00%
DIV收益率
Mayne Pharma Group Limited (MYX-AX) 财务报表
资产负债表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 229.2 | 97.1 | 98.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 127.5 | 1.3 | 0 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 209.5 | 283 | 193.3 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 82.7 | 108.9 | 102.5 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.2 | 22.6 | 22.3 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 553.6 | 511.6 | 416.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 51.5 | 225.9 | 221.6 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 22.1 | 20.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 617.3 | 427.5 | 636.2 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 617.3 | 449.6 | 656.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -22.1 | -20.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 23.4 | 133.7 | 187.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 2.3 | 4.5 | 16.7 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 694.5 | 791.5 | 1061.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 32 | 63.6 | 42.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 14.4 | 408 | 54 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.2 | 0 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 28.5 | 5.7 | 285.8 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 4.6 | 0 | 7 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 256.9 | 156.9 | 125.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 302.8 | 135.6 | 484 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.6 | 5.7 | 7 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 613.8 | 764.9 | 706.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 1233.7 | 1238.5 | 1238.5 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -769.8 | -840.3 | -559.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 170.4 | 147.7 | 88.9 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 634.4 | 545.9 | 768.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -7.7 | 3.2 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 634.4 | 538.2 | 771.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 127.5 | 1.3 | -20.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 47.5 | 413.7 | 346.8 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | -54.2 | 316.6 | 248.5 |
现金流量表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -317.4 | -209.5 | -208.4 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 50 | 63.4 | -43.9 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 6.8 | 4.6 | 7.7 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 145.4 | -8.9 | -13.6 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 118.7 | -66.1 | -3.2 | |||||||||||||||||
cash-flows.row.inventory | 0 | -12.1 | -2.4 | -25.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 45.3 | 60.7 | 16.4 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | -6.5 | -1.1 | -0.9 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 6.6 | 78.6 | 237.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 842.2 | 5.2 | 0 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -127.5 | 0 | 0 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -21.6 | -21.8 | -24.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 473.5 | -28.5 | -49.2 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -376 | -39.8 | -25.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -6.2 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -45.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -6.2 | 76.8 | -3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -431.5 | 37 | -28.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2.9 | 6.8 | -9 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4.6 | -1.3 | -39.8 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 101.7 | 97.1 | 98.4 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 97.1 | 98.4 | 138.2 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -43.1 | -16.6 | 47.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -262.7 | -28.5 | 22.2 |
利润表行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 183.6 | 157.1 | 400.8 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 156.7 | 133.4 | 273.8 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 26.8 | 23.7 | 127 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 213.3 | 145.6 | 125.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 370 | 279 | 399.4 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 6.7 | 0.5 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -186.4 | -121.9 | 1.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -269.7 | -145.6 | -263.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 47.7 | 74.5 | -54.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -316.4 | -281.3 | -208.4 |
常见问题
什么是 Mayne Pharma Group Limited (MYX.AX) 总资产是多少?
Mayne Pharma Group Limited (MYX.AX) 总资产为 1248134000.000.
什么是企业年收入?
年收入为 N/A.
企业利润率是多少?
公司利润率为 0.437.
什么是公司自由现金流?
自由现金流为 -0.359.
什么是企业净利润率?
净利润率为 -0.897.
企业总收入是多少?
总收入为 -0.381.
什么是 Mayne Pharma Group Limited (MYX.AX) 净利润?{{符号}}净利润(净收入)是多少?
净利润(净收入)为 -316419000.000.
公司总债务是多少?
债务总额为 47505000.000.
营业费用是多少?
运营支出为 213282000.000.
公司现金是多少?
企业现金为 0.000.